sodium salicylate has been researched along with Cytomegalovirus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laegreid, A; Thommesen, L | 1 |
Epstein, SE; Ferrans, VJ; Huang, ES; Speir, E; Yu, ZX | 1 |
2 other study(ies) available for sodium salicylate and Cytomegalovirus
Article | Year |
---|---|
Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB.
Topics: beta-Galactosidase; Cell Line, Tumor; Colonic Neoplasms; Cytomegalovirus; Enhancer Elements, Genetic; Genes, Reporter; Humans; NF-kappa B; Promoter Regions, Genetic; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Sodium Salicylate; Tetradecanoylphorbol Acetate | 2005 |
Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells.
Topics: Antiviral Agents; Aspirin; Cells, Cultured; Coronary Vessels; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytomegalovirus; Cytopathogenic Effect, Viral; Dexamethasone; Dinoprostone; Free Radical Scavengers; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Indomethacin; Isoenzymes; Membrane Proteins; Muscle Proteins; Muscle, Smooth, Vascular; NF-kappa B; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Sodium Salicylate; Sulfonamides; Transcriptional Activation; Viral Proteins; Virus Replication | 1998 |